A pharma giant is moving past one patent cliff — but another is already looming
Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.
시장
A pharma giant is moving past one patent cliff — but another is already looming
TradeNews BD, 주식·FX·암호화폐 테이프 (2026-10-30): Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks. 1차 출처: CNBC Top News 원문 (cnbc.com).